Which has better valuation & earnings, OABIW or BFRGW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OmniAb $38.46M N/A N/A N/A N/A Bullfrog AI $298.80K N/A N/A N/A N/A

Is OABIW or BFRGW more profitable?

Company Net Margins Return on Equity Return on Assets OmniAb N/A N/A N/A Bullfrog AI N/A N/A N/A

Which has stronger earnings & valuation, TBIO or OABIW?

OmniAb has lower revenue, but higher earnings than Telesis Bio. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Telesis Bio $225.09M 0.00 -$47.72M -$20.52 N/A OmniAb $38.46M N/A N/A N/A N/A

Is TBIO or OABIW more profitable?

OmniAb has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Telesis Bio -336.59% N/A -61.89% OmniAb N/A N/A N/A

Do analysts rate OABIW or TMO?

Thermo Fisher Scientific has a consensus price target of $634.86, suggesting a potential downside of 3.55%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than OmniAb. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OmniAb 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Thermo Fisher Scientific 2 Sell rating(s) 3 Hold rating(s) 18 Buy rating(s) 2 Strong Buy rating(s) 2.80

Which has higher earnings and valuation, OABIW or TMO?

Thermo Fisher Scientific has higher revenue and earnings than OmniAb. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OmniAb $38.46M N/A N/A N/A N/A Thermo Fisher Scientific $44.56B 5.46 $6.70B $18.59 35.41

Do analysts rate OABIW or DHR?

Danaher has a consensus price target of $235.23, suggesting a potential upside of 6.85%. Given Danaher's stronger consensus rating and higher probable upside, analysts clearly believe Danaher is more favorable than OmniAb. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OmniAb 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Danaher 0 Sell rating(s) 4 Hold rating(s) 17 Buy rating(s) 2 Strong Buy rating(s) 2.91

Which has stronger valuation & earnings, OABIW or DHR?

Danaher has higher revenue and earnings than OmniAb. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OmniAb $38.46M N/A N/A N/A N/A Danaher $25.11B 6.16 $3.61B $5.63 39.10

Is OABIW or DHR more profitable?

Danaher has a net margin of 15.95% compared to OmniAb's net margin of 0.00%. Danaher's return on equity of 11.04% beat OmniAb's return on equity. Company Net Margins Return on Equity Return on Assets OmniAb N/A N/A N/A Danaher 15.95% 11.04% 6.81%

Do analysts prefer OABIW or A?

Agilent Technologies has a consensus target price of $171.82, indicating a potential upside of 0.63%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Agilent Technologies is more favorable than OmniAb. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OmniAb 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Agilent Technologies 0 Sell rating(s) 4 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.79

Which has preferable valuation & earnings, OABIW or A?

Agilent Technologies has higher revenue and earnings than OmniAb. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OmniAb $38.46M N/A N/A N/A N/A Agilent Technologies $6.95B 6.93 $1.30B $5.08 33.61

OmniAb (OABIW) Competitors

$0.38 -0.01 (-1.28%)

As of 09:31 AM Eastern

Compare

OABIW vs. BFRGW, TBIO, TMO, DHR, and A

Should you buy OmniAb stock or one of its competitors? OmniAb's main competitors and comparable companies include Bullfrog AI (BFRGW), Telesis Bio (TBIO), Thermo Fisher Scientific (TMO), Danaher (DHR), and Agilent Technologies (A). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does OmniAb compare to Bullfrog AI?

OmniAb (NASDAQ:OABIW) and Bullfrog AI (NASDAQ:BFRGW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

Company	Net Margins	Return on Equity	Return on Assets
OmniAb	N/A	N/A	N/A
Bullfrog AI	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniAb	$38.46M	N/A	N/A	N/A	N/A
Bullfrog AI	$298.80K	N/A	N/A	N/A	N/A

In the previous week, Bullfrog AI had 1 more articles in the media than OmniAb. MarketBeat recorded 2 mentions for Bullfrog AI and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.79 beat Bullfrog AI's score of -0.11 indicating that OmniAb is being referred to more favorably in the media.

Company	Overall Sentiment
OmniAb	Very Positive
Bullfrog AI	Neutral

Summary

OmniAb beats Bullfrog AI on 2 of the 3 factors compared between the two stocks.

How does OmniAb compare to Telesis Bio?

Telesis Bio (NASDAQ:TBIO) and OmniAb (NASDAQ:OABIW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

OmniAb has lower revenue, but higher earnings than Telesis Bio.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Telesis Bio	$225.09M	0.00	-$47.72M	-$20.52	N/A
OmniAb	$38.46M	N/A	N/A	N/A	N/A

OmniAb has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%.

Company	Net Margins	Return on Equity	Return on Assets
Telesis Bio	-336.59%	N/A	-61.89%
OmniAb	N/A	N/A	N/A

37.6% of Telesis Bio shares are held by institutional investors. 24.5% of Telesis Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, OmniAb had 1 more articles in the media than Telesis Bio. MarketBeat recorded 1 mentions for OmniAb and 0 mentions for Telesis Bio. OmniAb's average media sentiment score of 1.79 beat Telesis Bio's score of 0.00 indicating that OmniAb is being referred to more favorably in the news media.

Company	Overall Sentiment
Telesis Bio	Neutral
OmniAb	Very Positive

Summary

OmniAb beats Telesis Bio on 4 of the 7 factors compared between the two stocks.

How does OmniAb compare to Thermo Fisher Scientific?

OmniAb (NASDAQ:OABIW) and Thermo Fisher Scientific (NYSE:TMO) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

Thermo Fisher Scientific has higher revenue and earnings than OmniAb.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniAb	$38.46M	N/A	N/A	N/A	N/A
Thermo Fisher Scientific	$44.56B	5.46	$6.70B	$18.59	35.41

Thermo Fisher Scientific has a net margin of 15.04% compared to OmniAb's net margin of 0.00%. Thermo Fisher Scientific's return on equity of 17.09% beat OmniAb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OmniAb	N/A	N/A	N/A
Thermo Fisher Scientific	15.04%	17.09%	8.12%

Thermo Fisher Scientific has a consensus price target of $634.86, suggesting a potential downside of 3.55%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than OmniAb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OmniAb	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Thermo Fisher Scientific	2 Sell rating(s)	3 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.80

In the previous week, Thermo Fisher Scientific had 40 more articles in the media than OmniAb. MarketBeat recorded 41 mentions for Thermo Fisher Scientific and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.79 beat Thermo Fisher Scientific's score of 1.18 indicating that OmniAb is being referred to more favorably in the media.

Company	Overall Sentiment
OmniAb	Very Positive
Thermo Fisher Scientific	Positive

89.2% of Thermo Fisher Scientific shares are owned by institutional investors. 0.3% of Thermo Fisher Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Thermo Fisher Scientific beats OmniAb on 11 of the 12 factors compared between the two stocks.

How does OmniAb compare to Danaher?

OmniAb (NASDAQ:OABIW) and Danaher (NYSE:DHR) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, media sentiment, institutional ownership, risk and analyst recommendations.

In the previous week, Danaher had 66 more articles in the media than OmniAb. MarketBeat recorded 67 mentions for Danaher and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.79 beat Danaher's score of 1.45 indicating that OmniAb is being referred to more favorably in the media.

Company	Overall Sentiment
OmniAb	Very Positive
Danaher	Positive

Danaher has a consensus price target of $235.23, suggesting a potential upside of 6.85%. Given Danaher's stronger consensus rating and higher probable upside, analysts clearly believe Danaher is more favorable than OmniAb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OmniAb	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Danaher	0 Sell rating(s)	4 Hold rating(s)	17 Buy rating(s)	2 Strong Buy rating(s)	2.91

Danaher has higher revenue and earnings than OmniAb.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniAb	$38.46M	N/A	N/A	N/A	N/A
Danaher	$25.11B	6.16	$3.61B	$5.63	39.10

79.1% of Danaher shares are held by institutional investors. 10.8% of Danaher shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Danaher has a net margin of 15.95% compared to OmniAb's net margin of 0.00%. Danaher's return on equity of 11.04% beat OmniAb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OmniAb	N/A	N/A	N/A
Danaher	15.95%	11.04%	6.81%

Summary

Danaher beats OmniAb on 11 of the 12 factors compared between the two stocks.

How does OmniAb compare to Agilent Technologies?

OmniAb (NASDAQ:OABIW) and Agilent Technologies (NYSE:A) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, dividends, risk, earnings, media sentiment and valuation.

Agilent Technologies has a consensus target price of $171.82, indicating a potential upside of 0.63%. Given Agilent Technologies' stronger consensus rating and higher possible upside, analysts clearly believe Agilent Technologies is more favorable than OmniAb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OmniAb	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Agilent Technologies	0 Sell rating(s)	4 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.79

Agilent Technologies has higher revenue and earnings than OmniAb.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OmniAb	$38.46M	N/A	N/A	N/A	N/A
Agilent Technologies	$6.95B	6.93	$1.30B	$5.08	33.61

Agilent Technologies has a net margin of 19.53% compared to OmniAb's net margin of 0.00%. Agilent Technologies' return on equity of 24.45% beat OmniAb's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OmniAb	N/A	N/A	N/A
Agilent Technologies	19.53%	24.45%	13.09%

In the previous week, Agilent Technologies had 4 more articles in the media than OmniAb. MarketBeat recorded 5 mentions for Agilent Technologies and 1 mentions for OmniAb. OmniAb's average media sentiment score of 1.79 beat Agilent Technologies' score of 0.72 indicating that OmniAb is being referred to more favorably in the media.

Company	Overall Sentiment
OmniAb	Very Positive
Agilent Technologies	Positive

Summary

Agilent Technologies beats OmniAb on 8 of the 9 factors compared between the two stocks.

Get OmniAb News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OABIW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OABIW vs. The Competition

Export

Metric	OmniAb	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$10.60B	$7.27B	$13.26B
Dividend Yield	N/A	1.45%	2.53%	22.58%
P/E Ratio	N/A	32.47	275.62	25.98
Price / Sales	N/A	105.75	583.29	80.65
Price / Cash	N/A	27.28	27.30	36.12
Price / Book	N/A	6.34	10.83	6.14
Net Income	N/A	$56.67B	$3.50B	$381.00M
7 Day Performance	33.68%	-3.70%	-1.40%	-1.62%
1 Month Performance	40.00%	7.81%	-4.19%	-3.54%
1 Year Performance	129.17%	30.84%	6.83%	1.14%

OmniAb Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OABIW OmniAb	N/A	$0.39 -1.3%	N/A	+129.2%	$0.00	$38.46M	N/A	89	Positive News
BFRGW Bullfrog AI	N/A	$0.16 +5.4%	N/A	-71.8%	$0.00	$298.80K	N/A	9	News Coverage Short Interest Increase Gap Up
TBIO Telesis Bio	N/A	N/A	N/A	N/A	$0.00	$225.09M	N/A	200
TMO Thermo Fisher Scientific	4.0859 of 5 stars	$652.25 -3.4%	$628.78 -3.6%	+25.4%	$241.17B	$44.56B	35.09	125,000	Positive News
DHR Danaher	3.8428 of 5 stars	$211.47 -4.5%	$232.50 +9.9%	+8.7%	$148.66B	$24.57B	37.56	60,000	Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OABIW) was last updated on 10/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OmniAb (OABIW) Competitors